Moreover, EMT was promoted in CAFs-derived CM- or IL-6-treated CCA cells as confirmed by down-regulation of E-cadherin and up-regulation of N-cadherin, slug, MMP-2 and fibronectin (Fig. 7E). The gene discussed is MMP2; the disease is cholangiocarcinoma.